Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password
PMLiVE Top Pharma List

11

Revenue 2017

AstraZeneca

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of AstraZeneca's 2013 sales performance.

Astra Zeneca

AstraZeneca receives CHMP recommendations for Imfinzi, Enhertu and Lynparza

AstraZeneca receives CHMP recommendations for Imfinzi, Enhertu and Lynparza AstraZeneca (AZ) has received recommendations for Imfinzi, Enhertu and Lynparza from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human use (CHMP) for the treatment of biliary tract

ICR calls for further discussions following NICE’s rejection of breast cancer drug

ICR calls for further discussions following NICE’s rejection of breast cancer drug The Institute of Cancer Research (ICR) has called for further discussions between AstraZeneca (AZ), NHS England and the National Institute for Health and Care Excellence (NICE) following the decision not to

AZ and Avillion’s asthma rescue treatment recommended by FDA Advisory Committee

AZ and Avillion’s asthma rescue treatment recommended by FDA Advisory Committee PT027 significantly reduced the risk of severe asthma exacerbations. AstraZeneca (AZ) and Avillion’s PT027 (albuterol/budesonide) has been recommended by the US Food and Drug Administration’s (FDA) Pulmonary-Allergy

Finalists 2022

by AstraZeneca. with support from Complete HealthVizion. Sanofi: Coaching Excellence That Increased Patient Share. ... The Reliever Reliance Test (RRT). by Spoonful of Sugar Ltd. Funded by AstraZeneca.

AstraZeneca’s Farxiga shows benefits for heart failure patients in phase 3 trial

AstraZeneca’s Farxiga shows benefits for heart failure patients in phase 3 trial AstraZeneca’s (AZ) Farixga (dapagliflozin) improved symptom burden and health-related quality of life in patients with heart failure and mildly reduced or preserved ejection fraction compared with placebo, according to

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

Global Data

Data provided by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

The challenges of identifying rare diseases
With increased awareness and improved diagnosis, more rare diseases are being recognised and this number is likely to increase in the coming years...
5 ways we’re enhancing our services to support our clients in 2023
Fishawack Health CEO Jon Koch explains the new platforms, tools, and services we’re elevating to drive innovation for our clients in 2023....
ASH 2022: bad blood but big advances
Five trends from this year’s ASH conference – and why even pop icons can’t compete with the playlist of innovation shaping haematology...

Quick links